Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344538 · ClinicalTrials.gov registry record · Phase 2
Ginger for Colorectal Cancer Prevention
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT01344538 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 30 participants.
The verdict
NCT01344538, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if ginger root extract when taken daily for 28 days is able to decrease levels of inflammatory chemicals called eicosanoids in the gut tissue of people who are at normal risk and those at increased of developing colorectal cancer compared to people taking placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo Capsule
- DRUG Ginger Root Extract (Pure Encapsulations)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01344538
The ClinicalTrials.gov registry entry for NCT01344538 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Capsule is the first listed.
NCT01344538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01344538 about?
NCT01344538 is a clinical study titled "Ginger for Colorectal Cancer Prevention". The purpose of this study is to determine if ginger root extract when taken daily for 28 days is able to decrease levels of inflammatory chemicals called eicosanoids in the gut tissue of people who are at normal risk and those at increased of developing colorectal cancer compared to people taking pl...
What is the current status of trial NCT01344538?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2007-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01344538?
The interventions under investigation include: Placebo Capsule (DIETARY_SUPPLEMENT), Ginger Root Extract (Pure Encapsulations) (DRUG).
Who is sponsoring clinical trial NCT01344538?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.